市場調查報告書
商品編碼
1451402
按測試類型(TSH 測試、T3 測試、T4 測試等)、適應症(甲狀腺功能減退症、甲狀腺功能亢進、甲狀腺癌等)、最終用戶(醫院、診斷實驗室等)和地區分類的甲狀腺功能測試市場報告2024 -2032Thyroid Function Test Market Report by Test Type (TSH Tests, T3 Tests, T4 Tests, and Others), Indication (Hypothyroidism, Hyperthyroidism, Thyroid Cancer, and Others), End User (Hospitals, Diagnostic Laboratories, and Others), and Region 2024-2032 |
2023年全球甲狀腺功能檢測市場規模達16億美元。展望未來, IMARC Group預計到2032年市場規模將達到26億美元,2024-2032年複合年成長率(CAGR)為5.1%。
甲狀腺功能測試用於測量血液中激素的水平。他們幫助醫療保健專業人員診斷甲狀腺炎、結節、癌症、腫瘤、甲狀腺腫、格雷夫斯病、橋本病、甲狀腺功能亢進症和甲狀腺功能減退症等疾病。醫生建議評估甲狀腺功能的一些測試包括三碘甲狀腺原氨酸 (T3)、甲狀腺素 (T4)、降鈣素、甲狀腺球蛋白、甲狀腺抗體和促甲狀腺激素 (TSH)。目前,促甲狀腺素受體自體抗體(TRAb)升高的嬰兒數量不斷增加,骨齡提前,顱縫早閉等甲狀腺相關疾病的風險很高。因此,對甲狀腺功能測試的需求增加,以篩檢新生兒是否有甲狀腺遺傳問題。
某些藥物(例如胺碘酮和鋰)以及第 1 型糖尿病、乳糜瀉、艾迪生氏症、唐氏症和特納氏症等疾病會增加甲狀腺的風險。這與大量的醫療疾病和容易獲得的醫療服務相結合,是積極影響甲狀腺功能測試需求的重要因素之一。此外,甲狀腺激素維持大腦、心臟、肌肉和其他器官的功能,其分泌不足或過多會導致嚴重的健康惡化。隨著人們對早期診斷的認知不斷提高和診斷方式的改進,這一點正在促進市場的成長。除此之外,不斷成長的老年人口以及許多國家衛生機構支持的大量宣傳活動正在推動甲狀腺功能測試市場的發展。此外,由於嬰兒先天性疾病盛行率不斷上升,各國政府正計劃強制實施新生兒篩檢計畫。再加上父母對孩子健康的日益關注,正在推動市場的成長。
The global thyroid function test market size reached US$ 1.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.6 Billion by 2032, exhibiting a growth rate (CAGR) of 5.1% during 2024-2032.
Thyroid function tests are used to measure the levels of hormones in the blood. They help healthcare professionals diagnose diseases like thyroiditis, nodules, cancer, tumors, goiter, Graves', Hashimoto's, hyperthyroidism, and hypothyroidism. Some of the tests advised by doctors to evaluate thyroid function include triiodothyronine (T3), thyroxine (T4), calcitonin, thyroglobulin, thyroid antibody, and thyroid-stimulating hormone (TSH). Presently, there is a rise number of infants with elevated thyrotropin receptor autoantibodies (TRAb), advanced bone age, and craniosynostosis are at a high risk of developing thyroid-related conditions. As a result, there is an increase in the demand for thyroid function tests to screen newborn babies for inherited problems with the thyroid gland.
Certain medications, such as amiodarone and lithium, and conditions like Type 1 diabetes, Coeliac, Addison's, Down's, and Turner syndrome increase the risk of developing thyroid. This, in confluence with a plethora of medical ailments and easy access to healthcare services, represents one of the significant factors positively influencing the need for thyroid function tests. Moreover, thyroid hormones maintain the functions of the brain, heart, muscles, and other organs and their under or overproduction can lead to serious health deteriorations. This, along with the increasing awareness about early diagnosis and improving diagnostic modalities, is contributing to market growth. Besides this, the growing geriatric population and considerable number of awareness campaigns supported by health agencies of numerous countries are driving the market for thyroid function tests. Furthermore, governments of various countries are planning to mandate newborn screening programs due to the rising prevalence of congenital conditions among infants. This, coupled with the increasing concerns among parents about the health of their children, is bolstering the growth of the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global thyroid function test market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on test type, indication and end user.
TSH Tests
T3 Tests
T4 Tests
Others
Hypothyroidism
Hyperthyroidism
Thyroid Cancer
Others
Hospitals
Diagnostic Laboratories
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Autobio Diagnostics Co. Ltd, bioMerieux SA, Diagnostic Automation/Cortez Diagnostics Inc., DiaSorin S.p.A., F. Hoffmann-La Roche AG, Merck KGaA, Qualigen Inc., Quidel Corporation, Siemens AG, and Thermo Fisher Scientific Inc.